The role of immune-reactions in patients with COVID-19

The role of immune-reactions in patients with COVID-19 - Covid-Immun

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00021810

Enrollment

1000

Registered

2020-05-27

Start date

2020-03-18

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

U07.1

Interventions

Group 1: non-interventional study, medical data of included patients is collected and analyzed. In addition, biosamples (blood, urine, stool) are taken at predefined time points.

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: confirmed COVID-19 infection or suspicion of COVID-19

Exclusion criteria

Exclusion criteria: For the prospective investigation: lack of consent, correctional facilities. In general (both prospective and retrospective): patients < 18 years.

Design outcomes

Primary

Measure	Time frame
Analysis of immune reactions in combination with clinical parameters. Blood-, stool-, and urine samples are taken at the day of admission and at day 7, 10, 13 (counted after symptom onset) and eyery further third day, and in addition on days of deterioration.	—

Secondary

Measure	Time frame
Collection and anaylsis of follow-up data of patients on a regular follow-up intervall basis with special focus on pulmonary long-term outcome.	—

Countries

Germany

Contacts

Public ContactUta Merle

Universitätsklinikum Heidelberg

uta.merle@med.uni-heidelberg.de004962215638709

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026